Discovery of novel gene mutations in leukemia patients opens up personalized therapy options

Specific mutations (N676K) in the FLT3 receptor can contribute to the development of acute myeloid leukemia. The FLT3 receptor regulates cell growth, while activating gene mutations promote the uncontrolled proliferation of white blood cells.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/2...